<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35143770</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-4650</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Lancet. Child &amp; adolescent health</Title><ISOAbbreviation>Lancet Child Adolesc Health</ISOAbbreviation></Journal><ArticleTitle>Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.</ArticleTitle><Pagination><StartPage>230</StartPage><EndPage>239</EndPage><MedlinePgn>230-239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-4642(22)00022-0</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-4642(22)00022-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">We describe post-COVID symptomatology in a non-hospitalised, national sample of adolescents aged 11-17 years with PCR-confirmed SARS-CoV-2 infection compared with matched adolescents with negative PCR status.</AbstractText><AbstractText Label="METHODS">In this national cohort study, adolescents aged 11-17 years from the Public Health England database who tested positive for SARS-CoV-2 between January and March, 2021, were matched by month of test, age, sex, and geographical region to adolescents who tested negative. 3 months after testing, a subsample of adolescents were contacted to complete a detailed questionnaire, which collected data on demographics and their physical and mental health at the time of PCR testing (retrospectively) and at the time of completing the questionnaire (prospectively). We compared symptoms between the test-postive and test-negative groups, and used latent class analysis to assess whether and how physical symptoms at baseline and at 3 months clustered among participants. This study is registered with the ISRCTN registry (ISRCTN 34804192).</AbstractText><AbstractText Label="FINDINGS">23&#x2009;048 adolescents who tested positive and 27&#x2009;798 adolescents who tested negative between Jan 1, 2021, and March 31, 2021, were contacted, and 6804 adolescents (3065 who tested positive and 3739 who tested negative) completed the questionnaire (response rate 13&#xb7;4%). At PCR testing, 1084 (35&#xb7;4%) who tested positive and 309 (8&#xb7;3%) who tested negative were symptomatic and 936 (30&#xb7;5%) from the test-positive group and 231 (6&#xb7;2%) from the test-negative group had three or more symptoms. 3 months after testing, 2038 (66&#xb7;5%) who tested positive and 1993 (53&#xb7;3%) who tested negative had any symptoms, and 928 (30&#xb7;3%) from the test-positive group and 603 (16&#xb7;2%) from the test-negative group had three or more symptoms. At 3 months after testing, the most common symptoms among the test-positive group were tiredness (1196 [39&#xb7;0%]), headache (710 [23&#xb7;2%]), and shortness of breath (717 [23&#xb7;4%]), and among the test-negative group were tiredness (911 [24&#xb7;4%]), headache (530 [14&#xb7;2%]), and other (unspecified; 590 [15&#xb7;8%]). Latent class analysis identified two classes, characterised by few or multiple symptoms. The estimated probability of being in the multiple symptom class was 29&#xb7;6% (95% CI 27&#xb7;4-31&#xb7;7) for the test-positive group and 19&#xb7;3% (17&#xb7;7-21&#xb7;0) for the test-negative group (risk ratio 1&#xb7;53; 95% CI 1&#xb7;35-1&#xb7;70). The multiple symptoms class was more frequent among those with positive PCR results than negative results, in girls than boys, in adolescents aged 15-17 years than those aged 11-14 years, and in those with lower pretest physical and mental health.</AbstractText><AbstractText Label="INTERPRETATION">Adolescents who tested positive for SARS-CoV-2 had similar symptoms to those who tested negative, but had a higher prevalence of single and, particularly, multiple symptoms at the time of PCR testing and 3 months later. Clinicians should consider multiple symptoms that affect functioning and recognise different clusters of symptoms. The multiple and varied symptoms show that a multicomponent intervention will be required, and that mental and physical health symptoms occur concurrently, reflecting their close relationship.</AbstractText><AbstractText Label="FUNDING">UK Department of Health and Social Care, in their capacity as the National Institute for Health Research, and UK Research and Innovation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK. Electronic address: t.stephenson@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Stavola</LastName><ForeName>Bianca L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McOwat</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zavala</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahoney</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawley</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Academic Child Health, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harnden</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swann</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Paediatric Infectious Disease, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Paediatrics and Child Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CLoCk Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, UK; Paediatric Infectious Diseases Research Group, St George's University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_19059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P020372/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Child Adolesc Health</MedlineTA><NlmUniqueID>101712925</NlmUniqueID><ISSNLinking>2352-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Child Adolesc Health. 2022 Apr;6(4):216-217. doi: 10.1016/S2352-4642(22)00035-9</RefSource><PMID Version="1">35143769</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet Child Adolesc Health. 2022 Jul;6(7):e21. doi: 10.1016/S2352-4642(22)00151-1</RefSource><PMID Version="1">35526538</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests TS is Chair of the Health Research Authority and therefore recused himself from the research ethics application. TC is a member of the National Institute for Health and Care Excellence committee for long COVID. She has written self-help books on chronic fatigue and has done workshops on chronic fatigue and post infectious syndromes. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buszewicz</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crawley</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Stavola</LastName><ForeName>Bianca L</ForeName><Initials>BL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Shruti</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hargreaves</LastName><ForeName>Dougal</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harnden</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poustie</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Segal</LastName><ForeName>Terry</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Kishan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swann</LastName><ForeName>Olivia</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>10</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35143770</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pii">S2352-4642(22)00022-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5:708&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky JR, Tao G, Lavery AM, et al. Late conditions diagnosed 1-4 months following an initial coronavirus disease 2019 (COVID-19) encounter: a matched-cohort study using inpatient and outpatient administrative data&#x2014;United States, March 1&#x2013;June 30, 2020. Clin Infect Dis. 2021;73(suppl 1):S5&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegelhalter D, Masters A. Penguin Random House; UK: 2021. Covid by numbers: making sense of the pandemic with data.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK Statistical bulletins. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/previousReleases</Citation></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, et al. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study) BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladhani SN, Baawuah F, Beckmann J, et al. SARS-CoV-2 infection and transmission in primary schools in England in June&#x2013;December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health. 2021;5:417&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9764982</ArticleId><ArticleId IdType="pubmed">33740430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Maskell K, Bannister PG, et al. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review. BMC Med. 2020;18:190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315698</ArticleId><ArticleId IdType="pubmed">32586391</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Digital  Mental Health of Children and Young People in England, 2020: wave 1 follow up to the 2017 survey. 2020. https://tinyurl.com/NHSWave1FU</Citation></Reference><Reference><Citation>Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry. 2001;40:1337&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pubmed">11699809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant R, Hiller L, Fishwick R, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2222612</ArticleId><ArticleId IdType="pubmed">18042300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille N, Badia X, Bonsel G, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19:875&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892611</ArticleId><ArticleId IdType="pubmed">20405245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>McCutcheon AC. Sage; Beverly Hills, CA, USA: 1987. Latent class analysis.</Citation></Reference><Reference><Citation>Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163&#x2013;W194.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938389</ArticleId></ArticleIdList></Reference><Reference><Citation>Oehlert GW. A note on the delta method. Am Stat. 1992;46:27&#x2013;29.</Citation></Reference><Reference><Citation>Rimes KA, Goodman R, Hotopf M, Wessely S, Meltzer H, Chalder T. Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study. Pediatrics. 2007;119:e603&#x2013;e609.</Citation><ArticleIdList><ArticleId IdType="pubmed">17332180</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Mental health of children and young people in Great Britain, 2004. 2004. https://files.digital.nhs.uk/publicationimport/pub06xxx/pub06116/ment-heal-chil-youn-peop-gb-2004-rep1.pdf</Citation></Reference><Reference><Citation>Creswell C, Shum A, Pearcey S, Skripkauskaite S, Patalay P, Waite P. Young people's mental health during the COVID-19 pandemic. Lancet Child Adolesc Health. 2021;5:535&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9765398</ArticleId><ArticleId IdType="pubmed">34174991</ArticleId></ArticleIdList></Reference><Reference><Citation>Skripkauskaite S, Shum A, Pearcey S, Raw J, Waite P, Creswell C. Report 08: changes in children's and young people's mental health symptoms: March 2020 to January 2021. 2021. https://cospaceoxford.org/wp-content/uploads/2021/02/Report_08_17.02.21.pdf</Citation></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021 doi: 10.1101/2021.06.28.21259452. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2018;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6257251</ArticleId><ArticleId IdType="pubmed">30270423</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis C, Chalder T. Concern for Covid-19 cough, fever and impact on mental health. What about risk of Somatic Symptom Disorder? J Ment Health. 2021;30:551&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">33522343</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connell K, Berluti K, Rhoads SA, Marsh AA. Reduced social distancing early in the COVID-19 pandemic is associated with antisocial behaviors in an online United States sample. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7790541</ArticleId><ArticleId IdType="pubmed">33412567</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Hiam L, Sowemimo A, Devakumar D, McKee M. Ethnicity and covid-19. BMJ. 2020;369</Citation><ArticleIdList><ArticleId IdType="pubmed">32527732</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Coronavirus (COVID-19) Infection Survey: technical data. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/covid19infectionsurveytechnicaldata</Citation></Reference><Reference><Citation>Ward H, Cooke GS, Atchison C, et al. Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: serial cross-sectional studies of 365&#x2008;000 adults. Lancet Reg Health Eur. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8088780</ArticleId><ArticleId IdType="pubmed">33969335</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>